Joshi Abhay

CIK 00013590892 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001359089

Recent Transactions

41 trades

Tax Payment
Revance Therapeutics, Inc.
Common Stock
2022-03-15$15.79/sh−2,607→ 120,708 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2022-02-15$13.35/sh−2,151→ 126,217 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2022-02-15$13.35/sh−2,902→ 123,315 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2021-03-15$27.73/sh−1,354→ 128,368 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2021-02-15$28.97/sh−1,967→ 132,603 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2021-02-15$28.97/sh−2,881→ 129,722 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-02+40,925→ 40,925 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-02-02+22,620→ 134,570 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-09-30+17,500→ 119,332 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2020-09-30$25.14/sh−7,382→ 111,950 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2020-03-15$15.50/sh−1,354→ 101,832 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2020-02-15$25.33/sh−3,325→ 103,186 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2020-01-23+146,500→ 146,500 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-01-23+25,000→ 106,511 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2020-01-15$22.89/sh−4,441→ 81,511 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2019-12-14$15.99/sh−2,971→ 85,952 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2019-03-15$15.45/sh−1,354→ 88,923 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2019-03-14−666→ 0 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2019-03-14$15.59/sh−166→ 90,277 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2019-03-14$4.20/sh+666→ 90,443 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2019-02-15$17.69/sh−1,510→ 89,777 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2019-01-24+94,000→ 94,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2019-01-24+15,750→ 91,287 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2019-01-15$20.19/sh−4,466→ 75,537 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2018-12-14$19.91/sh−4,260→ 80,003 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2018-03-21$2.55/sh+666→ 84,263 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-21−666→ 0 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2018-02-15$31.75/sh−1,509→ 83,597 total
Award
Revance Therapeutics, Inc.
Common Stock
2018-02-08+11,750→ 85,106 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-02-08+70,500→ 70,500 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2018-01-15$34.50/sh−4,327→ 73,356 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2017-12-14$32.15/sh−3,229→ 77,683 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2017-01-26+79,000→ 79,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2017-01-26+13,100→ 80,912 total
Award
Revance Therapeutics, Inc.
Common Stock
2016-12-15+36,000→ 67,812 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2016-12-14$16.70/sh−3,229→ 31,812 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2016-08-12$6.60/sh+666→ 35,041 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2016-08-12−666→ 0 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2015-12-14+206,250→ 206,250 total
Award
Revance Therapeutics, Inc.
Common Stock
2015-12-14+34,375→ 34,375 total
Award
COTHERIX INC
Stock Option (Right to Buy)
2006-06-30+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD

NEWARK, CA, 94560

View on SEC.gov